Health News Releases

March 17, 2020 14:48

Arima Genomics Completes Customer Validation and Launches Arima-HiChIP Kits and Services

Arima Genomics, Inc., a biotechnology company focused on accelerating the adoption of genome structure information toward medical research, diagnosis and therapy, announced today the full commercial l

March 16, 2020 16:28

GN MEDI Antibacterial Spray Which Sterilizes 99.99 Percent of Influenza A Virus Is Launched

Ventex launched GN MEDI 99.9% antibacterial spray which is an eco-friendly and odorless product containing harmless minerals for sterilization and disinfection. Ventex is a technical company in Kor

March 16, 2020 09:27

U.S. FDA grants Fast Track designation to empagliflozin for the treatment of chronic kidney disease

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for the investigation of empagliflozin to reduce the risk of kidney disease progression and cardiovascular death in adult

March 13, 2020 17:27

Siemens Korea donates 100 million won to help overcome novel coronavirus outbreak

Siemens Korea announced on March 13 that the company had donated 100 million won to the Korean Red Cross for supporting response efforts and stop the spread of COVID-19 outbreak. The donation was m

March 12, 2020 18:10

The Kidney Kid Superhero Initiative Goes International on World Kidney Day

Fresenius Medical Care, the world’s leading provider of dialysis products and services, has today announced the international and digital expansion of its highly successful Asia Pacific-wide Corporate

March 12, 2020 15:35

Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance

Regulatory News: Vifor Pharma Group recorded strong financial and operational performance in 2019 by focusing on its three strategic growth drivers while continuing to invest in its pipeline. The c

March 12, 2020 11:19

RELIEF THERAPEUTICS Holding SA (SIX: RLF) announces the proposal of Prof. Jonathan Javitt, M.D., M.P.H., at the upcoming general assembly as Vice Chairman of the Board

RELIEF THERAPEUTICS Holding SA (SIX-RLF, “Relief” or the “Company”) announces today that Prof. Jonathan C. Javitt, MD, MPH will be proposed for election as Vice-Chairman of its Board of Directors at t

March 11, 2020 15:39

Patient Safety Movement Foundation Appoints New Chairman; Announces Drive Toward Zero Preventable Patient Deaths By 2030

Patient Safety Movement Foundation (PSMF) - a global non-profit dedicated to unifying those involved in the healthcare ecosystem, identifying challenges that are causing patient deaths, and creating a

March 11, 2020 14:36

Takeda Provides Update on TOURMALINE-MM2 Phase 3 Trial

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the results from the TOURMALINE-MM2 study designed to evaluate the addition of NINLARO™ (ixazomib) to lenalidomide

March 09, 2020 11:34

AJ Vaccines To Develop Vaccine for COVID-19

“This endeavor reiterates our ambition to serve the global community, not only with existing effective high-quality vaccines, but also with the development of innovative new vaccines to answer the cur

March 06, 2020 17:11

Terns Pharmaceuticals to Present Data from an Ongoing Phase 1 Clinical Trial of TERN-201, a SSAO Inhibitor in Development for NASH

Terns Pharmaceuticals, Inc., a global biopharmaceutical company focused on discovering and developing innovative therapies to treat non-alcoholic steatohepatitis (NASH) and cancer, today announced it

March 05, 2020 11:28

Takeda Initiates Development of a Plasma-Derived Therapy for COVID-19

Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) today will share with members of the United States Congress that it is initiating the development of an anti-SARS-CoV-2 polyclona

March 04, 2020 20:00

Takeda Completes Sale of Select OTC and Non-Core Assets to STADA

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products to STADA Arzneimittel AG (“STADA”

March 04, 2020 13:19

Aragen Bioscience, Inc. and University of Technology, Sydney Enter Into MoU to Support and Accelerate Biologics R&D in Australia

Aragen Bioscience, Inc, a fully owned subsidiary of GVK BIO and a leading large molecule CRO, and University of Technology Sydney (UTS), the top-ranked young university in Australia, are pleased to an

March 03, 2020 16:29

Takeda Completes Sale of Select OTC and Non-Core Assets to Acino

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select over-the-counter (OTC) and prescription ph

March 03, 2020 16:04

Takeda Receives Positive CHMP Opinion for ALUNBRIG® (brigatinib) as a First-Line Treatment for ALK+ Non-Small Cell Lung Cancer

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion re

March 03, 2020 16:00

PDCline Pharma Announces the Administration of a First Patient With Its Therapeutic Cancer Vaccine Candidate (PDClung01) Targeting Non-small Cell Lung Cancer

PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today that the first patient was dosed with its innovative

March 03, 2020 15:21

Takeda Agrees to Divest Select OTC and Non-Core Assets in Latin America to Hypera Pharma for $825 Million USD

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it has entered into an agreement to divest a portfolio of select non-core products exclusively in Latin Americ

March 02, 2020 13:44

Coronavirus IS a Pandemic — WHO, Declare It Now!

Since AIDS Healthcare Foundation (AHF) released a statement this past Tuesday calling for World Health Organization Director-General Dr. Tedros Adhanom Ghebreyesus to declare the novel coronavirus (CO

March 02, 2020 10:08

Boehringer Ingelheim receives positive CHMP opinion for nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease

Boehringer Ingelheim today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending granting marketin

March 02, 2020 10:06

Takeda Receives Positive CHMP Opinion for Subcutaneous Formulation of Vedolizumab for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommend

February 28, 2020 10:25

Boehringer Ingelheim Enters Discovery Stage Collaboration with Trutino Biosciences to Grow Its Cancer Immunology Portfolio with Novel Cytokine Platform

Boehringer Ingelheim and Trutino Biosciences today announced they have entered into a research collaboration and worldwide licensing agreement based on Trutino’s innovative On-Demand-Cytokine (ODC) pl

February 27, 2020 17:34

The Success of ReSound Technology Is Amplified and Multiplied for Even More People With Hearing Loss

GN Hearing, the innovation leader in hearing aid technology, today launches a range of exciting new ReSound hearing aid solutions, a move which is in line with the company’s continuous strategic focus

February 27, 2020 11:40

Takeda Acquires PvP Biologics Following Results of a Phase 1 Study of TAK-062 (Kuma062) for the Treatment of Celiac Disease

Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) announced that it has acquired PvP Biologics, Inc. following the conclusion of a Phase 1 proof-of-mechanism study of investigationa

February 26, 2020 11:49

Masimo and MS Westfalia GmbH (MSW) Expand Partnership to Add Masimo SedLine® Brain Function Monitoring, O3® Regional Oximetry, and Oxygen Reserve Index (ORi™) to the MSW Modular Point-of-Care Hybrid Jenny

Masimo (NASDAQ: MASI) and MS Westfalia GmbH (MSW) announced today that MSW will integrate additional Masimo measurement technologies into MSW’s plug-and-play hybrid Jenny platform, to help clinicians

News by Region

News by Industry